NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

Skitahoe,

Read the story of the third patient enrolled in the phase1 DCVAX-L clinical trial and his booster vaccinations.

Tom Jones (not his real name) was the third patient enrolled in that trial and has survived eight years since his diagnosis………….
Thereafter, patients received booster shots every three months until tumor progression or until they ran out of tumor tissue to pulse with dendritic cells
……….
Jones received his first DCVax injection in June 2003 and his last booster vaccination in February 2009.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278117/